Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial (COACH) comparing two methods to suppress thyrotropin in patients with advanced differentiated thyroid carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Advanced Differentiated Thyroid Gland Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING